Dr Arthur Avetisyan, PHARMD | |
3604 San Fernando Rd, Glendale, CA 91204-2917 | |
(818) 956-2104 | |
Not Available |
Full Name | Dr Arthur Avetisyan |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 3604 San Fernando Rd, Glendale, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154027357 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 75545 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Arthur Avetisyan, PHARMD 834 Graynold Ave, Glendale, CA 91202-2608 Ph: (818) 808-6855 | Dr Arthur Avetisyan, PHARMD 3604 San Fernando Rd, Glendale, CA 91204-2917 Ph: (818) 956-2104 |
News Archive
The Palmetto Health Board of Directors has unanimously approved the establishment of Palmetto Health Quality Collaborative, LLC, often referred to as an accountable care organization. The Quality Collaborative will be a physician-led, patient-centered, interdependent medical entity that focuses on best practices in clinical outcomes and evidence-based care. Palmetto Health will soon begin offering the more than 1,000 physicians on its medical staff an opportunity to join.
Researchers at Duke University and the National Institutes of Health have found a way to calm the fears of anxious mice with a drug that alters their brain chemistry. They've also found that human genetic differences related to the same brain chemistry influence how well people cope with fear and stress.
Cancer Research Technology (CRT), Merck Serono, a division of Merck KGaA, Darmstadt, Germany, Cancer Research UK, Cardiff University and The Institute of Cancer Research (ICR) are set to begin a major new research collaboration for the first time. This will provide substantial investment in research on the WNT signalling pathway in the hope of finding new drug targets.
Archimedes Pharma US Inc. today announced publication of results from a pivotal clinical study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).
› Verified 2 days ago
Rosemary Kahale, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Central Ave, Glendale, CA 91203 Phone: 818-637-2758 | |
Annie Ahhyun Kim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3943 San Fernando Rd, Glendale, CA 91204 Phone: 818-549-2270 | |
Dr. Linda Kalamkeryan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Stocker St, 105, Glendale, CA 91202 Phone: 818-433-8379 | |
Dr. Jane Kyun Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Anna Arutunyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 E Broadway, Glendale, CA 91205 Phone: 818-547-0170 | |
Dr. Monica Natalia Macias, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Terrace, Glendale, CA 91206 Phone: 818-409-8140 | |
Arash Akmal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3452 Country Club Dr, Glendale, CA 91208 Phone: 310-463-7326 |